Sunday, March 13, 2022 12:40:33 AM
Recent DRTS News
- Alpha Tau to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit • GlobeNewswire Inc. • 03/25/2024 12:50:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 09:13:56 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 09:05:04 PM
- Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/07/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:32:03 PM
- Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/20/2023 02:16:03 PM
- Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/20/2023 02:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/18/2023 04:09:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/29/2023 01:35:02 PM
- Alpha Tau to Participate in Sidoti Small-Cap Conference • GlobeNewswire Inc. • 11/29/2023 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2023 01:35:19 PM
- Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer • GlobeNewswire Inc. • 11/28/2023 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2023 11:18:04 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2023 01:35:02 PM
- Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer • GlobeNewswire Inc. • 11/20/2023 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 09:32:05 PM
- Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/16/2023 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 09:18:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 12:32:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2023 12:31:28 PM
- Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility • GlobeNewswire Inc. • 10/30/2023 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/24/2023 01:05:02 PM
- Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board • GlobeNewswire Inc. • 10/24/2023 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM